IPO
Explore our secure online trading, IPO bidding, mutual fund investments, and depository services, all designed to provide seamless transactions, expert insights, and real-time market access for smart investing
Gland Pharma Ltd
Gland Pharma Ltd
Registered Office : Sy No 143-148 150&151 Nr Gandi,X Roads D P Pally Dundigal,Hyderabad Telangana 500043 Phone : 91-40-30510999
Fax : 91-40-30510800
Email : investors@glandpharma.com
Website : www.glandpharma.com
Initial public offer of 43196968 equity shares of face value of Re. 1 each ("equity shares") of Gland Pharma Limited ("Company" or "Issuer") for cash at a price of Rs.1500 Per equity share (including a share premium of Rs.1499 per equity share) aggregating Rs.6479.55 crores (The "Offer") comprising a fresh issue of 8,333,333 equity shares aggregating up to Rs. 1250 crores on (The "fresh issue") and an offer for sale of 34,863,635 equity shares, including 19,368,686 equity shares by Fosun Pharma Industrial Pte. Ltd ("promoter selling shareholder") and 10,047,435 equity shares by Gland Celsus Bio Chemicals Private Limited, 3,573,014 equity shares By Empower Discretionary Trust, and 1,874,500 equity shares by Nilay Discretionary Trust (collectively, the "other selling shareholders" and collectively With the promoter selling shareholder are referred to as the "selling shareholders", and such equity shares, the "offered shares") aggregating up to Rs. 5229.55 crores (the "offer for sale"). The offer shall constitute 26.46% of the post-offer paid-up equity share capital of the company. The face value of Equity shares is Re.1 each. The offer price is Rs.1500 per equity share and is 1500 times the face value of the Equity Shares. The Anchor Investor Offer Price is Rs.1500 per Equity Share.
Opens On
Closes On
09-Nov-2020
11-Nov-2020
Application
Allotment
1,500.00
0.00
Minimum Application for shares in Nos : 10.0 Further Multiples of : 10.0
₹Cr
Lead Managers to the Issue
Project Cost (₹.Cr)
Project Financed through Current Offer (₹.Cr)
Post Issue Equity Share Capital (₹.Cr)
Issue Price (₹.Cr)
1,250.00
6,479.55
163.28
1,500.00
Citigroup Global Markets India Pvt Ltd
Haitong Securities India Pvt Ltd
Kotak Mahindra Capital Company Ltd
Nomura Financial Advisory & Sec. (India) Pvt Ltd
- Funding incremental working capital requirements of the company
- Funding capital expenditure requirements of the company
- General corporate purposes
- Fosun Pharma Indust. Pte. Ltd
- Shanghai Fosun Pharma. Group
- BSE
- NSE
- MUFG Intime India Pvt Ltd